Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,577.80
-18.60 (-1.17%)
Oct 20, 2025, 10:30 AM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 217.44 billion as of October 17, 2025. Its market cap has increased by 19.88% in one year.
Market Cap
217.44B
Enterprise Value
244.34B
Revenue
29.35B
Ranking
n/a
PE Ratio
56.30
Stock Price
1,577.80
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 217.44B, an increase of 162.91%. That is a compound annual growth rate of 12.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 217.44B | 16.28% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | 78.75B | 20.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,028.72B |
| Divi's Laboratories | 1,757.80B |
| Cipla | 1,274.33B |
| Apollo Hospitals Enterprise | 1,136.11B |
| Mankind Pharma | 1,022.24B |
| Zydus Lifesciences | 993.81B |
| Fortis Healthcare | 819.05B |
| Alkem Laboratories | 667.35B |